Skip to main content
. 2022 May 5;27:101817. doi: 10.1016/j.pmedr.2022.101817

Table 3.

Timeliness of vaccination by 24 months among American Indian/Alaska Native and non-Hispanic White Montana children born 2015–2017, by race/ethnicity (n = 21,652).

American Indian/Alaska Native
n = 3,630
Non-Hispanic White  
n = 18,022
Vaccine series All doses, all on time
n
(column %)
All doses, but not all on time
n
(column %)
Missing some or all doses
n
(column %)
All doses, all on time
n
(column %)
All doses, but not all on time
n
(column %)
Missing some or all doses
n
(column %)
Chi-squarep-value
Combined 7-vaccine series 839 (23.1) 1214 (33.4) 1577 (43.4) 7284 (40.4) 4308 (23.9) 6430 (35.7) < 0.001
Vaccines in combined 7-vaccine series:
Hepatitis B, 3 doses 2881 (79.4) 449 (12.4) 300 (8.3) 15,436 (85.7) 910 (5.1) 1676 (9.3) < 0.001
Diphtheria-tetanus-acellular pertussis, 4 doses 1077 (29.7) 1322 (36.4) 1231 (33.9) 10,052 (55.8) 4050 (22.5) 3920 (21.8) < 0.001
Haemophilus influenzae type b, 3 or 4 dosesa 1536 (42.3) 1255 (34.6) 839 (23.1) 11,243 (62.4) 2770 (15.4) 4009 (22.3) < 0.001
Pneumococcal conjugate, 4 doses 1252 (34.5) 1217 (33.5) 1161 (32.0) 11,045 (61.3) 3288 (18.2) 3689 (20.5) < 0.001
Poliovirus, 3 doses 1898 (52.3) 1296 (35.7) 436 (12.0) 13,849 (76.8) 2502 (13.9) 1671 (9.3) < 0.001
Measles-mumps-rubella, 1 dose 2521 (69.5) 742 (20.4) 367 (10.1) 14,252 (79.1) 2270 (12.6) 1500 (8.3) < 0.001
Varicella, 1 dose 2473 (68.1) 742 (20.4) 415 (11.4) 13,772 (76.4) 2392 (13.3) 1858 (10.3) < 0.001

a Depending on brand.